Clorox CoCLX
Price$80.65Intrinsic value$118.5247% above price

Financial Snapshot

Revenue, profitability, returns, debt, and capital allocation

Revenue $6.8B-4.7% YoYTTM through 31 Mar 2026
Net Income $756M+170.0% YoYTTM through 31 Mar 2026
Free Cash Flow $380MTTM through 31 Mar 2026

Margins

Current
Gross Margin43.2%
EBITDA Margin18.0%
Operating Margin17.3%
Net Margin11.2%

Returns

12.0%ROA
18.5%ROIC

Balance Sheet Health

Debt / Equity44.33x
Current Ratio0.53x
Net Debt$2.9B
Cash & Equivalents$1.2B

Quality Metrics

Altman Z-Score2.51
Piotroski F-Score7 / 9
FCF Margin5.6%
Rule of 4018.5
Earnings-Beat Rate75.0%

Multi-Year Trend

Revenue
'19'20'21'22'23'24'25
FY2025: $7.1B
Diluted EPS$6.15TTM
'19'20'21'22'23'24'25
FY2025: $6.52

Dividend

$2.48Per share, FY20262.85%Yield-11.4%5-yr growth

Capital Allocation

R&D Spend$116M
Capex Intensity2.9%
All values are periodic snapshots, not live quotes. Source dates are shown for reference.

Filing Detail Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Sign in / Sign up
AI-assisted, source-linked narrative; figures from company filings (SEC EDGAR) and market data. Dates shown per section. Not investment advice. Terms of Use.